Inside-Filings
Projekt anfragen

Legend Biotech Corp (LEGN)

Sentiment-Signal

42,3
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
61.8
1 neu, 0 erhöht, -1220850K $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Stammdaten

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in revlimid-refractory multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for the treatment of gastric cancer and T cell lymphoma. In addition, it is developing CAR-T product candidates targeting CD20/CD22/CD19 for the treatment of non-hodgkins lymphoma, diffuse large B-cell lymphoma, and acute lymphoblastic leukemia. Further, the company has product candidates in early preclinical and clinical development for the treatment of solid tumors as well as infectious diseases. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. Legend Biotech Corporation was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation.

Unternehmen & Branche

NameLegend Biotech Corp
TickerLEGN
CIK0001801198
BoerseUS
SektorHealthcare
IndustrieBiotechnology
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP00000LEGN
ISINUS00000LEGN7
TypADR
Marktkapitalisierung4,23 Mrd. USD
Beta0,08
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
FMR LLC24,268,223024,268,223527,591,163Neu+100,0%
WESTFIELD CAPITAL MANAGEMENT CO LP6,164,67706,164,677134,020,083Neu+100,0%
BlackRock, Inc.4,276,91304,276,91392,980,090Neu+100,0%
GOLDMAN SACHS GROUP INC2,174,53502,174,53547,274,391Neu+100,0%
ALLIANCEBERNSTEIN L.P.1,517,06701,517,06732,981,037Neu+100,0%
STATE STREET CORP1,516,36801,516,36832,965,840Neu+100,0%
JPMORGAN CHASE & CO993,6940993,69421,602,906Neu+100,0%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC956,8240956,82420,801,354Neu+100,0%
Capital International Investors941,6000941,60020,470,384Neu+100,0%
JOHNSON & JOHNSON814,5860814,58617,709,100Neu+100,0%
IvyRock Asset Management (HK) Ltd804,0000804,00017,478,960Neu+100,0%
MARSHALL WACE, LLP755,9530755,95316,434,418Neu+100,0%
Hudson Bay Capital Management LP575,0000575,00012,500,500Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC555,4360555,43611,980,293Neu+100,0%
TWO SIGMA INVESTMENTS, LP526,0700526,07011,436,762Neu+100,0%
MORGAN STANLEY482,5500482,55010,490,642Neu+100,0%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/480,1430480,14310,438,309Neu+100,0%
Walleye Capital LLC477,1630477,16310,373,524Neu+100,0%
Squarepoint Ops LLC409,9740409,9748,912,835Neu+100,0%
RENAISSANCE TECHNOLOGIES LLC402,8000402,8008,756,872Neu+100,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP357,0750357,0757,762,811Neu+100,0%
JANE STREET GROUP, LLC338,4230338,4237,357,316Neu+100,0%
CITADEL ADVISORS LLC312,7400312,7406,798,968Neu+100,0%
BANK OF AMERICA CORP /DE/287,5290287,5296,250,880Neu+100,0%
NORTHERN TRUST CORP276,1190276,1196,002,827Neu+100,0%
BARCLAYS PLC273,8200273,8205,952,847Neu+100,0%
HSBC HOLDINGS PLC266,1340266,1345,787,598Neu+100,0%
BNP PARIBAS FINANCIAL MARKETS264,9230264,9235,759,426Neu+100,0%
Candriam S.C.A.261,8150261,8155,692,100Neu+100,0%
Triata Capital Ltd252,6000252,6005,491,524Neu+100,0%
Legal & General Group Plc226,9500226,9504,933,892Neu+100,0%
UBS Group AG224,6120224,6124,883,066Neu+100,0%
Casdin Capital, LLC215,0000215,0004,674,100Neu+100,0%
NEW YORK STATE COMMON RETIREMENT FUND163,1480163,1483,546,838Neu+100,0%
Swiss National Bank161,2940161,2943,506,532Neu+100,0%
DEUTSCHE BANK AG\157,0340157,0343,413,919Neu+100,0%
VANGUARD GROUP INC149,6190149,6193,252,717Neu+100,0%
PANAGORA ASSET MANAGEMENT INC139,8930139,8933,041,274Neu+100,0%
Caption Management, LLC135,0000135,0002,934,900Neu+100,0%
CITIGROUP INC134,9970134,9972,934,835Neu+100,0%
GROUP ONE TRADING LLC118,2760118,2762,571,320Neu+100,0%
Pictet Asset Management Holding SA111,4650111,4652,423,249Neu+100,0%
Engineers Gate Manager LP106,1400106,1402,307,484Neu+100,0%
SEI INVESTMENTS CO103,0220103,0222,239,701Neu+100,0%
Raiffeisen Bank International AG100,0000100,0002,153,000Neu+100,0%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP91,725091,7251,994,102Neu+100,0%
TUDOR INVESTMENT CORP ET AL90,700090,7001,971,818Neu+100,0%
Walleye Trading LLC83,458083,4581,814,377Neu+100,0%
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC80,363080,3631,747,092Neu+100,0%
ROYAL LONDON ASSET MANAGEMENT LTD79,400079,4001,726,156Neu+100,0%

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Stand: 31.03.2026

FondsAnteileWert (USD)Anteil (%)
OPPENHEIMER & CO INC26,850485,717100.00

Hinweis

Erweitert ×